BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30573508)

  • 1. T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: a report of two cases with molecular characterization.
    Belhadj M; Mansour D; Kaltenbach S; Deau-Fischer B; Franchi P; Tamburini J; Chapuis N; Damotte D; Kosmider O; Burroni B; Bouscary D
    Haematologica; 2019 Mar; 104(3):e117-e120. PubMed ID: 30573508
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma.
    Hidalgo Lopez JE; Yabe M; Carballo-Zarate AA; Wang SA; Jorgensen JL; Ahmed S; Lee J; Li S; Schlette E; McDonnell T; Miranda RN; Medeiros LJ; Bueso-Ramos CE; Yin CC
    J Natl Compr Canc Netw; 2016 Aug; 14(8):939-44. PubMed ID: 27496109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?
    Ok CY; Yin CC; Yabe M; Bueso-Ramos CE; Miranda RN; Medeiros LJ; Konoplev SN
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e95-e100. PubMed ID: 24524924
    [No Abstract]   [Full Text] [Related]  

  • 4. Case Report: Endocapillary Glomerulopathy Associated With Large Granular T Lymphocyte Leukemia.
    Zhao T; Hu N; Yu X; Su T
    Front Immunol; 2021; 12():810223. PubMed ID: 35145513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong expression of SLAMF7 in natural killer/T-cell lymphoma and large granular lymphocyte leukemia - a prominent biomarker and potential target for anti-SLAMF7 antibody therapy.
    Elmaagacli AH; Salwender H; Jehn C; Dahmash F; Singh A; Wilson O; Pannenbeckers M; Niggemann C; Vierbuchen M
    Leuk Lymphoma; 2019 Dec; 60(13):3335-3338. PubMed ID: 31164030
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature.
    Alekshun TJ; Tao J; Sokol L
    Am J Hematol; 2007 Jun; 82(6):481-5. PubMed ID: 17205534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.
    Yabe M; Medeiros LJ; Wang SA; Tang G; Bueso-Ramos CE; Jorgensen JL; Bhagat G; Chen W; Li S; Young KH; Miranda RN
    Am J Surg Pathol; 2017 Jan; 41(1):82-93. PubMed ID: 27755009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature.
    Liu Y; Fan L; Zhao H; Xu W; Li J
    Oncotarget; 2017 May; 8(19):32292-32297. PubMed ID: 28427176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experience.
    Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
    Leuk Res; 2020 Mar; 90():106299. PubMed ID: 32035354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable outcome in a child with EBV-negative aggressive NK cell leukemia.
    Park JA; Jun KR; Nam SH; Ghim TT
    Int J Hematol; 2013 May; 97(5):673-6. PubMed ID: 23550023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
    Cornish N; Maybury B; Otton S
    Br J Haematol; 2018 Jan; 180(2):176. PubMed ID: 29048103
    [No Abstract]   [Full Text] [Related]  

  • 12. Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte Leukemia.
    Poh C; Arora M; Ghuman S; Tuscano J
    Acta Haematol; 2021; 144(1):95-99. PubMed ID: 32348994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center Series of Bone Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia: High Rates of Sustained Response to Oral Methotrexate.
    Munir T; Bishton MJ; Carter I; McMillan A; O'Connor S; Sovani V; Haynes AP; Fox CP
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):705-712. PubMed ID: 27640075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 + /NKa + /CD8(dim+) T-cell large granular lymphocytic leukemia: a rare entity.
    Dadu T; Rangan A; Bhargava M
    J Postgrad Med; 2010; 56(3):223-4. PubMed ID: 20739776
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence of T-cell lymphoma in a patient with acute myelogenous leukemia.
    Thomas X; Anglaret B; Treille-Ritouet D; Bastion Y; Fiere D; Archimbaud E
    Ann Hematol; 1996 Aug; 73(2):95-8. PubMed ID: 8774619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Large granular lymphocytic leukemia. A rare disease with personalized treatment options].
    Adamkovich N; Kispál M; Krenács L; Bagdi E; Borbényi Z
    Orv Hetil; 2014 Mar; 155(11):414-9. PubMed ID: 24613776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric immunophenotyping for the diagnosis of a rare T-LGL neoplasm.
    Vartholomatos G; Benetatos L
    J Postgrad Med; 2010; 56(3):255. PubMed ID: 20842810
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic EBV-positive T-cell lymphoma of childhood mimicking anaplastic large cell lymphoma.
    Chen Z; Liu W; Zhao S
    Br J Haematol; 2019 Jun; 185(6):1016. PubMed ID: 31172518
    [No Abstract]   [Full Text] [Related]  

  • 20. Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia.
    Garban F; Carras S; Drillat P; Jacob MC; Fabre B; Callanan M; Courby S; Makowski C; Cahn JY; Gressin R
    Ann Oncol; 2012 Sep; 23(9):2386-2390. PubMed ID: 22422944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.